| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 21.5 | 24.0 | 13.7 |
| Total income | 21.5 | 24.0 | 13.7 |
| Profit before exceptional items & tax | 0.4 | 0.9 | 0.1 |
| Profit before tax | 0.4 | 0.9 | 0.1 |
| Net profit | 0.2 | 0.7 | 0.1 |
| Operating margin | 1.9% | 3.8% | 0.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +100.00% |
|---|---|
| Net profit, quarter on quarter | -71.40% |
| Revenue, year on year | +56.90% |
BSE results filing, NSE: SHIVMED. Figures extracted from the filing.
Bandaram Pharma Packtech Ltd: key numbers
- Share price
- ₹19.52
- Market cap
- ₹35.08 Cr
- Revenue (annual)
- ₹62.92 Cr
- Net profit (annual)
- ₹1.01 Cr
- P/E (TTM)
- 34.5×Sector 52.0×
- Promoter holding
- 62.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bandaram Pharma Packtech Ltd
All →Bandaram Pharma Packtech Board Meeting Date
Bandaram Pharma Packtech will hold a board meeting on 29 October 2026 to consider September 2026 quarter results. The trading window stays closed until 16 November 2026.
Bandaram Pharma Packtech Other Announcement
Bandaram Pharma Packtech Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b). This is a standard periodic regulatory disclosure of the company's shareholding structure.
Bandaram Pharma Packtech Board Meeting Date
Bandaram Pharma Packtech has scheduled a board meeting on 30.09.2026 to consider a proposal for a scheme of arrangement or amalgamation.
Bandaram Pharma Packtech Annual General Meeting
Bandaram Pharma Packtech Limited held its Annual General Meeting on September 24, 2026, approving financial statements and re-appointing auditors and directors.
Bandaram Pharma Packtech Annual General Meeting
Bandaram Pharma Packtech submitted its Annual Report and notice for the AGM, which is now rescheduled for September 24, 2026.
Bandaram Pharma Packtech Management Change
Bandaram Pharma Packtech re-appointed its statutory auditor for 36 months and an independent director for a 60-month term, both approved in the board meeting.